HIMS
Hims Hers Health Inc
$26.58
+13.25%
Price vs EBITDA Yield
Current Valuation
- EBITDA Yield
- 1.41%
- EV/EBITDA
- 70.9x
- P/E Ratio
- 46.0x
- PEG Ratio
- 2.61
EV/EBITDA Averages
- Median (Fair Value)
- 125.7x
- Industry (Damodaran)
- 15.2x
- 1-Year Avg
- 70.9x
- 3-Year Avg
- 61.5x
- 5-Year Avg
- 56.1x
- Min / Max
- -408.5x / 213.1x
EBITDA Growth
- YoY Growth
- 496.2%
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- Current Margin
- 5.3%
Financial Snapshot
- Market Cap
- $5.35B
- Enterprise Value
- $5.89B
- Revenue (TTM)
- $2.35B
- Dividend Yield
- -
Valuation Context
vs 5-Year Average
26%
Above average (potentially overvalued)
EBITDA Yield
1.41%
Below average yield
vs Industry (Drugs (Pharmaceutica...)
365%
Above industry avg
Data Points
1253
daily data points